The effects of 1-(5'-oxohexyl)-3-methyl-7-propyl
xanthine (
HWA 285) on various experimentally induced
ulcers and gastric acid secretion were investigated in rats.
HWA 285 (10-50 mg/kg, p.o.) inhibited restraint and water-immersion-induced stress,
ulcers,
indometacin- and absolute
ethanol-induced
gastric ulcers and
mepirizole-induced
duodenal ulcers in rats in a dose-dependent manner.
HWA 285 (10-25 mg/kg i.d.) had inhibitory effects on
acetylsalicylic acid-induced
ulcers. The healing of
acetic acid-induced chronic
ulcers was significantly accelerated by
HWA 285 (25 mg/kg p.o.) when it was given twice daily for 7 consecutive days. When given orally (twice a day, 11 doses in total) before the induction of
gastric ulcers by stress,
cimetidine at 100 mg/kg aggravated the
ulcers, whereas,
HWA 285 at 25 mg/kg had not such an effect. In conscious pylorus-ligated rats,
HWA 285 (10-100 mg/kg i.p.) showed a dose-dependent inhibition on basal and
desglugastrin- and
2-deoxy-D-glucose (2-DG)-stimulated gastric acid secretion. In stomach-lumen perfused rats,
HWA 285 (30 mg/kg i.v.) inhibited 2-DG-stimulated gastric acid secretion but not
carbachol-stimulated gastric acid secretion. These results suggest that the anti-
ulcer effects of
HWA 285 are produced by cytoprotective and central anti-secretory activity without peripheral
anti-cholinergic properties. Whether the central anti-secretory effects of
HWA 285 play thereby the key role, have to be clarified in further investigation.